Abstract:Most clinical MRSA (methicillin-resistant S. aureus) isolates exhibit low-level β-lactam resistance (oxacillin MIC 2–4 μg/ml) due to the acquisition of a novel penicillin binding protein (PBP2A), encoded by mecA. However, strains can evolve high-level resistance (oxacillin MIC ≥256 μg/ml) by an unknown mechanism. Here we have developed a robust system to explore the basis of the evolution of high-level resistance by inserting mecA into the chromosome of the methicillin-sensitive S. aureus SH1000. Low-level mecA-dependent oxacillin resistance was associated with increased expression of anaerobic respiratory and fermentative genes. High-level resistant derivatives had acquired mutations in either rpoB (RNA polymerase subunit β) or rpoC (RNA polymerase subunit β') and these mutations were shown to be responsible for the observed resistance phenotype. Analysis of rpoB and rpoC mutants revealed decreased growth rates in the absence of antibiotic, and alterations to, transcription elongation. The rpoB and rpoC mutations resulted in decreased expression to parental levels, of anaerobic respiratory and fermentative genes and specific upregulation of 11 genes including mecA. There was however no direct correlation between resistance and the amount of PBP2A. A mutational analysis of the differentially expressed genes revealed that a member of the S. aureus Type VII secretion system is required for high level resistance. Interestingly, the genomes of two of the high level resistant evolved strains also contained missense mutations in this same locus. Finally, the set of genetically matched strains revealed that high level antibiotic resistance does not incur a significant fitness cost during pathogenesis. Our analysis demonstrates the complex interplay between antibiotic resistance mechanisms and core cell physiology, providing new insight into how such important resistance properties evolve.Methicillin resistant Staphylococcus aureus (MRSA) places a great burden on human healthcare systems. Resistance is mediated by the acquisition of a non-native penicillin-binding protein 2A (PBP2A), encoded by mecA. MRSA strains are resistant to virtually all β-lactam antibiotics, and can shift from being low- to high-level resistant. Prior studies have revealed the involvement of components of the core genome in increased resistance, but the underlying mechanism is still unknown. In this study, we have found that increased resistance is associated with mutations in either rpoB (RNA polymerase subunit β) or rpoC (RNA polymerase subunit β') resulting in slower growth and elevated levels of PBP2A. Furthermore, transcript profiling revealed that insertion of mecA triggered metabolic imbalance by altering anaerobic and fermentative gene expression, accompanied by low-level resistance whereas, acquisition of rpoB and rpoC mutations reversed gene expression to wild-type level and enabled cells to become highly-resistant. The mutations also affected RNA polymerase activity. A set of matched strains revealed that changes in antibiotic resistance levels do not have a significant cost in terms of pathogenic potential. Our study reveals a novel effect of mecA acquisition on central metabolism and sheds light on potential pathways essential for high-level resistance.

Low-Level Cefepime Exposure Induces High-Level Resistance in Environmental Bacteria: Molecular Mechanism and Evolutionary Dynamics.

High-Throughput Evolution Unravels Landscapes of High-Level Antibiotic Resistance Induced by Low-Level Antibiotic Exposure

Mutation-driven resistance development in wastewater E. coli upon low-level cephalosporins: pharmacophore contribution and novel mechanism

In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development

Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Mechanisms of Staphylococcus Aureus Antibiotics Resistance Revealed by Adaptive Laboratory Evolution

Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change

In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa

Unveiling a novel mechanism for competitive advantage of ciprofloxacin-resistant bacteria in the environment through bacterial membrane vesicles

Antibiotic dose and nutrient availability differentially drive the evolution of antibiotic resistance and persistence

Evolutionary trajectories of β-lactam resistance in Enterococcus faecalis strains

Biocide-Induced Emergence of Antibiotic Resistance in Escherichia coli

Evolutionary trajectories of resistant mutants during sub-MIC antibiotic exposure

Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression

Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition

Specific phenotypic, genomic, and fitness evolutionary trajectories toward streptomycin resistance induced by pesticide co-stressors in Escherichia coli

Porin deficiency or plasmid copy number increase mediated carbapenem-resistant Escherichia coli resistance evolution

Benzalkonium chloride forces selective evolution of resistance towards antibiotics in Salmonella enterica serovar Typhimurium

Emergence of Resistant Escherichia coli Mutants in Microfluidic On-Chip Antibiotic Gradients

Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide m-Chlorophenylhydrazone Selects for Mutations Affecting PMF-Driven Drug Efflux Pumps